CEACAM5 and neoplasm: During a five-year follow-up period (2015–2020), routine whole-body CT scans showed no recurrence or metastasis, and tumor markers (AFP, CEA, CA19-9) remained within normal limits, except for CA72–4 fluctuations (6.39–14.33 U/mL).